What's breaking now, across thousands of outlets.
(RTTNews) - Pharming Group N.V. (PHARM.AS) said the U.S. Food and Drug Administration has approved Joenja (leniolisib) for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome, or APDS, who weigh at least 27 kg.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
(MedPage Today) -- President Donald Trump, Vice President JD Vance, and other Republican officials came together for a 2-day convention this week to rally voters in advance of the midterm elections in…
(MedPage Today) -- Members of the American Diabetes Association (ADA) have launched a boycott against the organization, condemning leadership's actions in the aftermath of five researchers being…
President John Dramani Mahama has announced that health workers who accept postings to deprived and underserved areas will receive a 20% incentive on their basic salaries to encourage professionals to…
Every Scan. One Plan. One Platform. With Medicare coverage now finalized for asymptomatic severe aortic stenosis, cvi42 gives TAVR programs the automated planning, standardized reporting, and…
